Q2 2024 Holdings
Filed 2024-08-14 | 42 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Soleno Therapeutics Inc(SLNO) | Common | 834203309 | $298.5M | 7,316,851 | 27.6% |
| Geron Corp(GERN) | Common | 374163103 | $115.4M | 27,225,292 | 10.7% |
| Harmony Biosciences Holdings Inc(HRMY) | Common | 413197104 | $78.6M | 2,606,247 | 7.3% |
| Sinovac Biotech Ltd.(SVA) | SHS | P8696W104 | $76.3M | 11,800,000 | 7.1% |
| Dyne Therapeutics Inc(DYN) | Common | 26818M108 | $57.7M | 1,635,136 | 5.3% |
| Avadel Pharmaceuticals PLC | ADR | 05337M104 | $55.8M | 3,972,099 | 5.2% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $51.3M | 3,549,758 | 4.7% |
| Terns Pharmaceuticals Inc(TERN) | Common | 880881107 | $42.1M | 6,182,992 | 3.9% |
| ALX Oncology Holdings Inc(ALXO) | Common | 00166B105 | $25.4M | 4,220,048 | 2.4% |
| Viridian Therapeutics Inc(VRDN) | Common | 92790C104 | $21.8M | 1,678,207 | 2.0% |
| Astria Therapeutics Inc(CATBUSD) | Common | 04635X102 | $21.2M | 2,329,027 | 2.0% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $21.0M | 1,105,454 | 1.9% |
| Olema Pharmaceuticals Inc(OLMA) | Common | 68062P106 | $20.3M | 1,873,704 | 1.9% |
| Cogent Biosciences Inc(COGT) | Common | 19240Q201 | $18.9M | 2,244,941 | 1.7% |
| Erasca Inc(ERAS) | Common | 29479A108 | $15.9M | 6,756,756 | 1.5% |
| Tarsus Pharmaceuticals Inc(TARS) | Common | 87650L103 | $15.4M | 565,550 | 1.4% |
| Delcath Systems, Inc.(DCTH) | Common | 24661P807 | $14.0M | 1,666,746 | 1.3% |
| Rezolute Inc(RZLT) | Common | 76200L309 | $12.0M | 2,797,704 | 1.1% |
| Celcuity Inc(CELC) | Common | 15102K100 | $10.0M | 610,500 | 0.9% |
| Sera Prognostics Inc(SERA) | Common | 81749D107 | $9.8M | 1,650,440 | 0.9% |
| Compass Pathway PLC(CMPS) | SPONSORED ADS | 20451W101 | $9.7M | 1,608,000 | 0.9% |
| Zai Lab Ltd(ZLAB) | ADR | 98887Q104 | $9.2M | 531,198 | 0.9% |
| Oric Pharmaceuticals Inc(ORIC) | Common | 68622P109 | $9.0M | 1,269,676 | 0.8% |
| Regulus Therapeutics Inc(RGLS) | Common | 75915K309 | $8.9M | 5,000,000 | 0.8% |
| Abeona Therapeutics, Inc.(ABEO) | Common | 00289Y206 | $7.8M | 1,842,751 | 0.7% |
| Tourmaline Bio Inc.(TRML) | Common | 89157D105 | $7.6M | 591,882 | 0.7% |
| Corbus Pharmaceuticals Holdings(CRBP) | Common | 21833P301 | $7.5M | 166,794 | 0.7% |
| IO Biotech Inc(IOBT) | Common | 449778109 | $7.2M | 6,173,439 | 0.7% |
| Instil Bio Inc(TIL) | Common | 45783C200 | $6.4M | 624,339 | 0.6% |
| Engene Holdings Inc.(ENGN) | Common | 29286M105 | $6.4M | 678,705 | 0.6% |
| Verastem Inc(VSTM) | Common | 92337C203 | $4.6M | 1,538,461 | 0.4% |
| Compass Therapeutics Inc(CMPX) | Common | 20454B104 | $3.6M | 3,556,023 | 0.3% |
| Allakos Inc(ALLKGUSD) | Common | 01671P100 | $3.0M | 2,988,000 | 0.3% |
| Bolt Therapeutics Inc(BOLT1EUR) | Common | 097702104 | $2.6M | 3,521,291 | 0.2% |
| Unicycive Therapeutics | Common | 90466Y103 | $1.7M | 3,470,152 | 0.2% |
| Aligos Therapeutics Inc | Common | 01626L105 | $1.2M | 3,547,030 | 0.1% |
| Codexis, Inc(CDXS) | Common | 192005106 | $1.2M | 388,144 | 0.1% |
| DBV Technologies SA | SPONSORED ADS | 23306J200 | $1.1M | 1,354,437 | 0.1% |
| Adverum Biotechnologies, Inc.(AVU0) | Common | 00773U207 | $833.3K | 833,333 | 0.1% |
| Aadi Bioscience Inc(WHWK) | Common | 00032Q104 | $744.0K | 509,572 | 0.1% |
| Q32 Bio Inc.(QTTB) | Common | 746964105 | $369.0K | 20,559 | 0.0% |
| Precision Biosciences Inc(DTIL) | Common | 74019P207 | $45.5K | 4,675 | 0.0% |